NasdaqGS:XERSPharmaceuticals
Assessing Xeris Biopharma Holdings (XERS) Valuation Following Upgrades and Fresh Earnings Revisions
If you’ve been tracking Xeris Biopharma Holdings (XERS), you probably noticed the recent jump in excitement around the stock. A fresh wave of analyst upgrades and positive earnings estimate revisions have set the tone, reinforcing what momentum watchers have suspected: investors are taking another look at Xeris as near-term prospects brighten up. These triggers have moved sentiment quickly, and for anyone considering adding XERS to their portfolio, it feels like a moment when signals are...